|
ACTR3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.689500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.355770E-01 |
| Normal-vs-Stage2 |
5.567100E-04 |
| Normal-vs-Stage3 |
7.970400E-02 |
| Normal-vs-Stage4 |
2.086100E-02 |
| Stage1-vs-Stage2 |
1.101070E-03 |
| Stage1-vs-Stage3 |
5.483000E-01 |
| Stage1-vs-Stage4 |
1.148230E-01 |
| Stage2-vs-Stage3 |
1.601510E-02 |
| Stage2-vs-Stage4 |
1.503440E-01 |
| Stage3-vs-Stage4 |
3.748800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.508000E-02 |
| Normal-vs-AfricanAmerican |
1.633780E-01 |
| Normal-vs-Asian |
2.229700E-02 |
| Caucasian-vs-AfricanAmerican |
8.848000E-01 |
| Caucasian-vs-Asian |
1.803020E-01 |
| AfricanAmerican-vs-Asian |
4.782800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.417600E-02 |
| Normal-vs-Female |
5.775900E-02 |
| Male-vs-Female |
6.263200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.211000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.080000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.716300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.997000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.638000E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.146370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.660200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.338200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.254000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.993610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.936400E-01 |
| Classical-VS-Follicular |
1.62699999999294E-05 |
| Classical-VS-Other |
2.641200E-01 |
| Classical-VS-Normal |
1.764200E-01 |
| Tall-VS-Follicular |
1.089820E-02 |
| Tall-VS-Other |
2.614800E-01 |
| Tall-VS-Normal |
9.041200E-01 |
| Follicular-VS-Other |
7.286400E-01 |
| Follicular-VS-Normal |
4.776100E-04 |
| Other-VS-Normal |
1.910570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.101600E-03 |
| Normal-vs-N1 |
2.135700E-02 |
| N0-vs-N1 |
8.330000E-01 |
|
|
